Clinical Trials in South Korea

Active recruiting clinical trials with sites in South Korea. Select a condition below to see detailed trial listings.

Total Trials: 166 // Recruiting: 166 // Updated: Daily

South Korea currently has 166 clinical trials with at least one registered site in the country, of which 166 are actively recruiting participants. The most studied conditions at South Korea sites are Coronary Artery Disease, Gastric Cancer, Atrial Fibrillation (AF), reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Seoul National University Hospital, Samsung Medical Center, Yonsei University. By stage, active South Korea trials break down as Phase 1 (25), Phase 2 (38), Phase 3 (14), Phase 4 (12). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in South Korea

Coronary Artery Disease 6 Gastric Cancer 4 Atrial Fibrillation (AF) 3 Ovarian Cancer 3 Endometrial Cancer 3 Hepatocellular Carcinoma (HCC) 3 Ischemic Stroke 3 Stroke 3 Cardiovascular Diseases 3 Atrial Fibrillation 2 Advanced Solid Tumor 2 NSCLC 2 Dyslipidemias 2 Diabetes Mellitus, Type 2 2 BKV Infection 2 CMV Infection 2 EBV Infection 2 Dementia 2 Radioembolization 2 Ischemic Heart Disease 2

All Countries → All Trials →

Other Countries in This Region

🇦🇺Australia 🇯🇵Japan

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology